Philippines - English - FDA (Food And Drug Administration)

amb hk enterprises inc.; distributor: southmed pharma corporation - multivitamins , dextrose - solution for iv infusion - dextrose 25 g thiamine hydrochloride (vitamin b1) 125 mg riboflavin (vitamin b2) 25 mg nicotinamide (vitamin b3) 625 mg pyri

Philippines - English - FDA (Food And Drug Administration)

caan pharmaceutical co., inc.; distributor: arex health corporation - multivitamins,dextrose - solution for injection (iv) - thiamine hcl 5mg, riboflavin 1mg, nicotinamide 25mg, pyridoxine hcl 1mg,ascorbic acid 20mg, d-panthenol 10mg, dextrose 1g

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: sahar international trading, inc.; distributor: amediqo phils., inc. - multivitamins , dextrose - solution for injection (iv) - formulation: each 500 ml contains: dextrose-25 g d-panthenol -250mg ascorbic acid (vitamin c)-500mg thiamine hci (vitamin b1)-125mg riboflavin (vitamin b2)-25 mg pyridoxine hci (vitamin b6)-25mg nicotinamide -625 mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: sahar international trading, inc.; distributor: amson pharmaceuticals - multivitamins , dextrose - solution for injection (iv) - formulation: each 500 ml contains dextrose-25g d-panthenol-250mg ascorbic acid (vitamin c)-500mg thiamine hcl (vitamin b1)-125mg riboflavin (vitamin b2)-25 mg pyridoxine hci (vitamin b6)-25 mg nicotinamide-625mg

Philippines - English - FDA (Food And Drug Administration)

sahar international trading inc; distributor: ellebasy medicale group inc. - multivitamins , dextrose - solution for injection (iv) - formulation: each 500 ml. contains dextrose-25 mg d-panthenol-250mg ascorbic acid (vitamin c)-500mg thiamine hcl (vitamin b1)-125mg riboflavin (vitamin b2)-25mg pyridoxine hci (vitamin b6)-25mg nicotinamide-625mg

Philippines - English - FDA (Food And Drug Administration)

greencore pharma, inc.; distributor: greencore pharma, inc. - multivitamins , dextrose - solution for injection (i.v. infusion) - 25 g formulation: each 500 ml contains: dextrose (glucose) nicotinamide ascorbic acid (vitamin c) dexpanthenol thiamine hydr

Philippines - English - FDA (Food And Drug Administration)

nelpa lifesciences, inc.; distributor: nelpa lifesciences, inc. - multivitamins , dextrose - solution for injection (i.v. infusion) - formulation each 500 ml contains: dextrose nicotinamide ascorbic acid (vitamin c) d-panthenol thiamine hydrochloride (vitamin b1) riboflavin (vitamin b2) pyridoxine hydrochloride (vitamin b6) 625 mg 500 mg 250 mg 125 mg 25 mg 25 mg

Philippines - English - FDA (Food And Drug Administration)

sapphire lifesciences pvt. ltd.; importer: nelpa lifesciences, inc.; distributor: nelpa lifesciences, inc. - multivitamins , dextrose - solution for injection (i.v. infusion) - formulation each 500 ml contains: dextrose-25 g nicotinamide-625 mg ascorbic acid (vitamin c)-500 mg d-panthenol-250 mg thiamine hydrochloride (vitamin b1)-125 mg riboflavin (vitamin b2)-25mg pyridoxine hydrochloride (vitamin b6)-25mg

Philippines - English - FDA (Food And Drug Administration)

drugmaker's labs inc - multivitamins , minerals - tablet

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), soybean oil (unii: 241atl177a) (soybean oil - unii:241atl177a), sodium acetate (unii: 4550k0sc9b) (sodium cation - unii:lyr4m0nh37, acetate ion - unii:569dqm74sc), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), sodium glycerophosphate anhydrous (unii: yp1h63lj2k) (sodium cation - unii:lyr4m0nh37, phosphate ion - unii:nk08v8k8hr), magnesium sulfate heptahydrate (un - dextrose monohydrate 9.8 g in 100 ml - kabiven is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. kabiven may be used to prevent essential fatty acid deficiency or treat negative nitrogen balance in adult patients. limitations of use: kabiven is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see warnings and precautions (5.1) and use in specific populations (8.4)] . the use of kabiven is contraindicated in: - neonates (28 days of age or younger) receiving concomitant treatment with ceftriaxone, even if separate infusion lines are used, due to the risk of fatal ceftriaxone calcium salt precipitation in the neonate's bloodstream [see limitations of use (1), warnings and precautions (5.5), use in specific populations (8.4)]. - pat